225 related articles for article (PubMed ID: 2605100)
1. DNA content in high and intermediate grade non-Hodgkin's lymphoma-prognostic significance and clinicopathological correlations.
Cowan RA; Harris M; Jones M; Crowther D
Br J Cancer; 1989 Dec; 60(6):904-10. PubMed ID: 2605100
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
[TBL] [Abstract][Full Text] [Related]
3. DNA content and prognosis of non-Hodgkin's lymphoma.
Morgan DR; Williamson JM; Quirke P; Clayden AD; Smith ME; O'Brien CJ; Allison DL; Child JA; Bird CC
Br J Cancer; 1986 Oct; 54(4):643-9. PubMed ID: 3778806
[TBL] [Abstract][Full Text] [Related]
4. Prognostic relevance of ploidy and proliferative activity evaluation by flow cytometry in poor prognosis non-Hodgkin's lymphomas.
De Lena M; Barletta A; Marzullo F; Lorusso V; Berardi F; Tommasi S; Mangia A; Paradiso A
Haematologica; 1992; 77(1):84-6. PubMed ID: 1398287
[TBL] [Abstract][Full Text] [Related]
5. Prognostic indicators in centroblastic-centrocytic lymphoma.
Griffin NR; Howard MR; Quirke P; O'Brien CJ; Child JA; Bird CC
J Clin Pathol; 1988 Aug; 41(8):866-70. PubMed ID: 3170773
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of DNA flow cytometry in non-Hodgkin's lymphoma.
Wu HM
J Tongji Med Univ; 1992; 12(2):65-70. PubMed ID: 1433420
[TBL] [Abstract][Full Text] [Related]
7. Prognostic relevance of non-Hodgkin's lymphomas cell cycle data.
Vucković J; Forenpoher G; Marusić M; UZarević B; Zemunik T
Neoplasma; 1998; 45(5):332-5. PubMed ID: 9921923
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric DNA analysis: a prognostic tool in non-Hodgkin's lymphoma.
Christensson B; Lindemalm C; Johansson B; Mellstedt H; Tribukait B; Biberfeld P
Leuk Res; 1989; 13(4):307-14. PubMed ID: 2716347
[TBL] [Abstract][Full Text] [Related]
9. Analysis of ploidy and proliferative activity in childhood non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD).
Coad NA; Jones TJ; Muir KR; Parkes SE; Smith K; Raafat F; Mann JR
Pediatr Pathol Lab Med; 1997; 17(6):893-902. PubMed ID: 9353829
[TBL] [Abstract][Full Text] [Related]
10. Association of DNA content and proliferative activity with clinical outcome in patients with diffuse mixed cell and large cell non-Hodgkin's lymphoma.
Wooldridge TN; Grierson HL; Weisenburger DD; Armitage JO; Sanger WG; Collins MM; Pierson JL; Pauza ME; Fordyce R; Purtilo DT
Cancer Res; 1988 Nov; 48(22):6608-13. PubMed ID: 3052808
[TBL] [Abstract][Full Text] [Related]
11. DNA ploidy and cell kinetic characteristics in canine non-Hodgkin's lymphoma.
Teske E; Rutteman GR; Kuipers-Dijkshoorn NJ; van Dierendonck JH; van Heerde P; Cornelisse CJ
Exp Hematol; 1993 Apr; 21(4):579-84. PubMed ID: 8462667
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and predictive evaluation of DNA content, S-phase fraction and immunophenotyping in non-Hodgkin's lymphomas in adults. A prospective study.
Lackowska B; Gruchała A; Niezabitowski A; Radkowski A; Skołyszewski J; Ryś J; Szklarski W; Sokołowski A
Pol J Pathol; 1999; 50(1):23-9. PubMed ID: 10412271
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus-related lymphomas: a possible association between tumor proliferation, lack of ploidy anomalies, and immune deficiency.
McDunn SH; Winter JN; Variakojis D; Rademaker AW; Von Roenn JH; Tallman MS; Gordon LI; Bauer KD
J Clin Oncol; 1991 Aug; 9(8):1334-40. PubMed ID: 1677032
[TBL] [Abstract][Full Text] [Related]
14. Biologic progression in non-Hodgkin's lymphoma. A flow cytometric study.
Joensuu H; Klemi PJ; Jalkanen S
Cancer; 1990 Jun; 65(11):2564-71. PubMed ID: 2337874
[TBL] [Abstract][Full Text] [Related]
15. DNA flow cytometry of non-Hodgkin's lymphomas: correlation with cytologic grade and clinical relapse.
Saikia UN; Dey P; Vohra H; Gupta SK
Diagn Cytopathol; 2000 Mar; 22(3):152-6. PubMed ID: 10679994
[TBL] [Abstract][Full Text] [Related]
16. DNA ploidy, proliferative activities, and immunophenotype of malignant lymphoma: application of flow cytometry.
Horii A; Yoshida J; Hattori K; Honjo Y; Mitani K; Takashima S; Sakai M; Okamoto S; Kubo T
Head Neck; 1998 Aug; 20(5):392-8. PubMed ID: 9663666
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma.
Cowan RA; Jones M; Harris M; Steward WP; Radford JA; Wagstaff J; Deakin DP; Crowther D
Br J Cancer; 1989 Feb; 59(2):276-82. PubMed ID: 2930692
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of DNA ploidy and proliferative activity in Hodgkin's disease.
Joensuu H; Klemi PJ; Korkeila E
Am J Clin Pathol; 1988 Dec; 90(6):670-3. PubMed ID: 3195496
[TBL] [Abstract][Full Text] [Related]
19. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of DNA ploidy status in patients with rectal cancer.
Berczi C; Bocsi J; Bartha I; Math J; Balazs G
Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]